Ditchcarbon
  • Contact
  1. Organizations
  2. American Regent, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

American Regent, Inc. Sustainability Profile

Company website

American Regent, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 1988, the company has established itself as a leader in the development and manufacturing of injectable pharmaceuticals, particularly in the areas of anaesthesia and critical care. With a diverse portfolio that includes essential products such as injectable solutions and specialty pharmaceuticals, American Regent is recognised for its commitment to quality and innovation. The company has achieved significant milestones, including the expansion of its manufacturing capabilities and a robust pipeline of new products. Renowned for its reliability and dedication to patient safety, American Regent continues to strengthen its market position, making notable contributions to healthcare providers and patients alike.

DitchCarbon Score

How does American Regent, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

74

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

American Regent, Inc.'s score of 74 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.

85%

Let us know if this data was useful to you

American Regent, Inc.'s reported carbon emissions

Inherited from Daiichi Sankyo Company, Limited

American Regent, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Daiichi Sankyo Company, Limited, and thus may inherit emissions data and climate commitments from its parent organisation. While American Regent, Inc. has not set its own reduction targets or initiatives, it is aligned with the sustainability efforts of Daiichi Sankyo Company, Limited. This includes participation in various climate initiatives such as the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and RE100, which aim to promote significant reductions in greenhouse gas emissions across the corporate family. As a subsidiary, American Regent, Inc. is expected to adhere to the climate commitments and performance standards set by Daiichi Sankyo, which may include ambitious targets for reducing Scope 1, 2, and 3 emissions. However, specific details regarding these targets or achievements have not been disclosed at this time. In summary, while American Regent, Inc. does not currently report its own emissions data or reduction targets, it is part of a larger corporate structure that is committed to addressing climate change through established initiatives and frameworks.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20112012201320142015201620172018201920202021202220232024
Scope 1
182,519,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
290,715,000
000,000,000
000,000,000
000,000,000
-
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
5,704,000
-
-
-
-
-
-
-
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is American Regent, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. American Regent, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is American Regent, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for American Regent, Inc. is in US, which has a low grid carbon intensity relative to other regions.

American Regent, Inc.'s Scope 3 Categories Breakdown

American Regent, Inc.'s Scope 3 emissions, which decreased by 6% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 85% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
85%
Capital Goods
5%
Downstream Transportation & Distribution
4%
Upstream Transportation & Distribution
3%
Business Travel
1%
Fuel and Energy Related Activities
<1%
End-of-Life Treatment of Sold Products
<1%
Waste Generated in Operations
<1%
Employee Commuting
<1%
Downstream Leased Assets
<1%

American Regent, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

American Regent, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare American Regent, Inc.'s Emissions with Industry Peers

Fresenius Kabi USA, LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Lupin Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Sandoz Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

Cipla USA Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Akorn

US
•
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

Apotex Corp.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251125.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy